Tachycardia, Supraventricular
Conditions
Keywords
Supraventricular tachycardia, Radiation exposure
Brief summary
Observational study is to demonstrate a clinically significant reduction of ionizing radiation exposure during transcatheter ablation of supraventricular tachycardias using the EnSite precision mapping system in a real-world clinical setting without compromising efficacy and safety.
Interventions
Electrophysiology Study and Ablation of Supraventricular Arrhythmias
Sponsors
Study design
Eligibility
Inclusion criteria
* Male or female patients ≥ 18 years of age * Patient indicated for supraventricular arrhythmias ablation according to the current guidelines * Patient is willing to provide written informed consent.
Exclusion criteria
* Patient is pregnant. * Contraindications to ionizing radiation exposure * Patient's life expectancy is less than 1 year * Associated complex congenital heart disease * Cardiac implantable electric devices * Known pathological venous access to the heart
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Radiation exposure dose | The day of performing the procedure | The dose of ionizing radiation exposure in patients undergoing Supraventricular Tachycardia catheter ablation utilizing a non-fluoroscopic EnSite Precision 3D mapping system |
| Incidence of procedure related cardiac Adverse Events (Safety) | 6 months | Cardiac related serious adverse events frequency during and after ablation procedure of supraventricular arrhythmias |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fluoroscopy time | The day of performing the procedure | Fluoroscopy time during the procedure |
Countries
Bahrain